RLMD · Relmada Therapeutics, Inc. · Documents
$3.36
+0.20 (+6.33%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$337.08M
Shares
106.67M
Volume · Oct 20
740.29K
Avg daily vol (3M)
1.26M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2021-03-31 | 2021-05-20 | |
| 10-K | — | 2021-03-24 | 2020-12-31 | |
| 8-K | — | 2021-03-23 | — | |
| 8-K | — | 2021-03-15 | — | |
| 8-K | — | 2021-03-15 | — | |
| 8-K | — | 2021-01-07 | 2021-01-06 | |
| 8-K | — | 2021-01-05 | 2020-12-31 | |
| 8-K | — | 2020-12-14 | — | |
| 8-K | — | 2020-12-08 | 2020-12-07 | |
| 8-K | — | 2020-11-16 | — | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-10-27 | — | |
| 10-Q | — | 2020-08-12 | 2020-06-30 | |
| 8-K | — | 2020-06-03 | 2020-06-02 | |
| 10-Q | — | 2020-05-15 | 2020-03-31 | |
| 8-K/A | — | 2020-04-06 | 2020-03-06 | |
| 8-K | — | 2020-03-12 | 2020-03-06 | |
| 8-K | — | 2020-03-09 | 2020-03-06 | |
| DEF 14A | — | 2020-01-31 | 2020-03-06 | |
| 8-K | — | 2020-01-10 | 2020-01-09 |
Showing 101–120 of 120 filings